Metrika članka

  • citati u SCindeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[=>]
  • posete u poslednjih 30 dana:7
  • preuzimanja u poslednjih 30 dana:1
članak: 3 od 6  
Back povratak na rezultate
Vojnosanitetski pregled
2017, vol. 74, br. 10, str. 970-973
jezik rada: engleski
vrsta rada: kratki članak
doi:10.2298/VSP151108195S

Creative Commons License 4.0
Povezanost između vrednosti C-reaktivnog proteina i normotenzivnog glaukoma
aRailway Health Institute, Ophthalmology Department, Belgrade
bUniversity of Belgrade, Faculty of Medicine, Belgrade + Clinical Centre of Serbia, Clinic for Eye Diseases, Belgrade
cUniverzitet u Beogradu, Medicinski fakultet, Institut za medicinsku statistiku i informatiku
dPrimary Health Centre 'Euromedic', Belgrade
eHealth Center Kosovska Mitrovica, Kosovska Mitrovica + University of Priština/Kosovska Mitrovica, Faculty of Medicine, Kosovska Mitrovica

e-adresa: milanstojcic@gmail.com

Sažetak

Uvod/Cilj. C-reaktivni protein (CRP) je sistemski inflamatorni marker koji je povezan sa rizikom od nastanka kardiovaskularnih bolesti (KVB). Određeni faktori rizika od KVB su ujedno i faktori rizika od razvoja normotenzivnog glaukoma (NTG), ali povezanost između CRP I NTG još uvek nije jasno definisana. Cilj ove studije bio je da se ispita povezanost između vrednosti visokosenzitivnog CRP u plazmi kod bolesnika sa NTG i u kontrolnoj grupi. Metode. Ispitano je ukupno 20 bolesnika sa NTG (4 muškaraca i 16 žena) i 25 osoba iz kontrolne grupe (5 muškaraca i 20 žena). Obe grupe ispitanika imale su približno iste demografske karakteristike (godine, pol i indeks telesne mase) i kod obe grupe bili su prisutni vaskularni faktori rizika u istom procentu. Rezultati. Vrednosti CRP u plazmi bolesnika sa NTG i u kontrolnoj grupi bile su poredive: srednja vrednost iznosila je 4.99 ± 0.77 mg/L, mediana 4.50 mg/L, opseg 2.50-18.90 mg/L kod bolesnika sa NTG, dok su te vrednosti u kontrolnoj grupi bile: 4.19 ± 0.30 mg/L, 3.50 mg/L, odnosno 2.20-8.50. Zaključak. Rezultati dobijeni u ovoj studiji pokazuju da vrednosti CRP nisu povećene kod bolesnika sa NTG.

Ključne reči

Reference

Casson, R.J., Chidlow, G., Wood, J.P., Crowston, J.G., Goldberg, I. (2012) Definition of glaucoma: clinical and experimental concepts. Clinical & Experimental Ophthalmology, 40(4): 341-349
Choi, J., Joe, S.G., Seong, M., Choi, J.Y., Sung, K.R., Kook, M.S. (2009) C-reactive Protein and Lipid Profiles in Korean Patients With Normal Tension Glaucoma. Korean Journal of Ophthalmology, 23(3): 193
de Voogd, S., Wolfs, R.C. W., Jansonius, N.M., Witteman, J.C. M., Hofman, A., de Jong, P.T. V. M. (2006) Atherosclerosis, C-Reactive Protein, and Risk for Open-Angle Glaucoma: The Rotterdam Study. Investigative Opthalmology & Visual Science, 47(9): 3772
Drance, S.M. (2008) What can we learn from the disc appearance about the risk factors in glaucoma?. Canadian journal of ophthalmology, 43(3): 322-7
Flammer, J., Orgül, S., Costa, V.P., Orzalesi, N., Krieglstein, G.K., Metzner, S.L., i dr. (2004) The impact of ocular blood flow in glaucoma. Prog Retin Eye Res, 21(4), str. 359-93
Flammer, J., Konieczka, K., Flammer, A.J. (2013) The primary vascular dysregulation syndrome: implications for eye diseases. EPMA Journal, 4(1):
Galassi, F., Giambene, B., Varriale, R. (2011) Systemic vascular dysregulation and retrobulbar hemodynamics in normal-tension glaucoma. Investigative ophthalmology & visual science, 52(7): 4467-71
Gasser, P. (1998) Why study vascular factors in glaucoma?. International Ophthalmology, 22(4): 221-225
Gherghel, D., Hosking, S., Orgul, S. (2004) Autonomic nervous system, circadian rhythms, and primary open-angle glaucoma. Survey of Ophthalmology, 49(5): 491-508
Grieshaber, M.C., Flammer, J. (2005) Blood flow in glaucoma. Current Opinion in Ophthalmology, 16(2): 79-83
Harris, A., Jonescu-Cuypers, C., Martin, B., Kagemann, L., Zalish, M., Garzozi, H.J. (2001) Simultaneous management of blood flow and IOP in glaucoma. Acta Ophthalmologica Scandinavica, 79(4): 336-341
Hayreh, S.S. (1999) Retinal and optic nerve head ischemic disorders and atherosclerosis:. Progress in Retinal and Eye Research, 18(2): 191-221
Hayreh, S.S. (1999) The Role of Age and Cardiovascular Disease in Glaucomatous Optic Neuropathy. Survey of Ophthalmology, 43: S27-S42
Kamal, D., Hitchings, R. (1998) Normal tension glaucoma: A practical approach. British journal of ophthalmology, 82(7): 835-40
Lee, N.Y., Park, H.L., Park, C.K., Ahn, M.D. (2012) Analysis of Systemic Endothelin-1, Matrix Metalloproteinase-9, Macrophage Chemoattractant Protein-1, and High-Sensitivity C-Reactive Protein in Normal-Tension Glaucoma. Current Eye Research, 37(12): 1121-1126
Leibovitch, I., Kurtz, S., Kesler, A., Feithliher, N., Shemesh, G., Sela, B. (2005) C-Reactive Protein Levels in Normal Tension Glaucoma. Journal of Glaucoma, 14(5): 384-386
Levene, R.Z. (1980) Low tension glaucoma: A critical review and new material. Survey of Ophthalmology, 24(6): 621-664
Mazer, S.P., Rabbani, L.E. (2004) Evidence for C-Reactive Protein's Role in (CRP) Vascular Disease: Atherothrombosis, Immuno-Regulation and CRP. Journal of Thrombosis and Thrombolysis, 17(2): 95-105
Pache, M., Flammer, J. (2006) A Sick Eye in a Sick Body? Systemic Findings in Patients with Primary Open-angle Glaucoma. Survey of Ophthalmology, 51(3): 179-212
Pasceri, V., Willerson, J.T., Yeh, E.T. (2000) Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation, 102(18): 2165-8
Pepys, M.B., Hirschfield, G.M. (2003) C-reactive protein: A critical update. J Clin Invest, 111(12): 1805-12
Ridker, P.M. (2001) High-sensitivity C-reactive protein: Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation, 103(13): 1813-8
Shields, B.M. (2008) Normal-tension glaucoma: Is it different from primary open-angle glaucoma?. Current Opinion in Ophthalmology, 19(2): 85-88
Shoshani, Y.Z., Harris, A., Shoja, M.M., Rusia, D., Siesky, B., Arieli, Y., Wirostko, B. (2012) Endothelin and Its Suspected Role in the Pathogenesis and Possible Treatment of Glaucoma. Current Eye Research, 37(1): 1-11
Stefan, C., Nenciu, A., Melinte, D., Malcea, C., Nae, I., Afanasiuc, O. (2006) Protein C reactive and glaucoma. Oftalmologia (Bucharest), 50(4): 82-5
Su, W., Ho, W., Cheng, S., Chang, S.H. L., Wu, S. (2007) Systemic High-sensitivity C-reactive Protein Levels in Normal-tension Glaucoma and Primary Open-angle Glaucoma. Journal of Glaucoma, 16(3): 320-323
Sugiyama, T., Moriya, S., Oku, H., Azuma, I. (1995) Association of endothelin-1 with normal tension glaucoma: Clinical and fundamental studies. Survey of Ophthalmology, 39: S49-S56
Torzewski, M., Rist, C., Mortensen, R. F., Zwaka, T. P., Bienek, M., Waltenberger, J., Koenig, W., Schmitz, G., Hombach, V., Torzewski, J. (2000) C-Reactive Protein in the Arterial Intima : Role of C-Reactive Protein Receptor-Dependent Monocyte Recruitment in Atherogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology, 20(9): 2094-2099